1 P1 purinoceptor agonists like adenosine have been shown to stimulate Cl-transport in secretory epithelia. In the present study, we investigated whether P1 agonist-induced Cl-secretion is preserved in cystic fibrosis airway epithelium and which signalling mechanism is involved. The effects of purinoceptor agonists on Cl-secretion were examined in a transformed cystic fibrosis airway phenotype epithelial cell line, CFPEo-. 2 Addition of adenosine (ADO; 0.1-1 mM) markedly increased 1251 efflux rate. The rank order of potency of purinoceptor agonists in stimulating 1251I efflux was ADO>AMP>ADP-ATP. A similar order of potency was seen in transformed cystic fibrosis nasal polyp cells, CFNPEo-(ADO>ATP > AMP> ADP). These results are consistent with the activation of Cl-secretion via a P1 purinoceptor. 3 The P1 agonists tested (at 0.01 and 0.1 mM) revealed a rank order of potency of 5'-Nethylcarboxamine adenosine (NECA)>2-chloro-adenosine (2-Cl-ADO)>R-phenylisopropyl adenosine (R-PIA). 4 The known potent A2 adenosine receptor (A2AR) agonist, 5'-(N-cyclopropyl) carboxamidoadenosine (CPCA, 2 JiM) but not the A1 adenosine receptor agonist, N6-phenyl adenosine (N6-phenyl ADO, 10 ELM) markedly increased 1251 efflux rate (baseline, 5.9 ± 2.0% min-', + CPCA, 10.9 ± 0.6% min-'; P<0.01). The stimulant effect of CPCA (10 gLM) was abolished by addition of the A2AR antagonist 3,7-dimethyl-1-propargylxanthine (DMPX) (100 ,.m; reported Ki = 11 ± 3 fiM). These results favour the involvement of A2AR. 6 In patch-clamp experiments, ADO (1 mM) induced an outwardly-rectified whole-cell Cl-current (baseline, 2.5 ± 0.8 pA pF-, + ADO, 78.4 ± 23.8 pA pF-'; P<0.02), which was largely inhibited in cells internally perfused with a selective inhibitory peptide of the multifunctional Ca2+/calmodulindependent protein kinase, CaMK (20 gM), as compared to a control peptide, CaMK [284][285][286][287][288][289][290][291][292][293][294][295][296][297][298][299][300][301][302]. Addition of BAPTA (10 mM), a Ca2+ chelator, to the perfusion pipette also abolished the ADO-elicited Cl-current. 7 In conclusion, our results suggest that A2AR participates in regulation of airway C1 secretion via a Ca2+-dependent signalling pathway, which involves CaMK and appears to be at least partially conserved in cystic fibrosis airway epithelial cells.
Introduction
Cystic fibrosis (CF) is the most common inherited fatal disease among Caucasians, with an estimated incidence of 1 in 2000 to 3000 newborns (Boat et al., 1989) . The primary physiological defect associated with CF is altered salt and water transport in epithelial cells (Boat et al., 1989; Anderson et al., 1992) which is normally regulated by an adenosine 3': 5'-cyclic monophosphate (cyclic AMP) dependent pathway. Considerable efforts have been made in recent years to improve epithelial Cl-secretion through alternate signaltransduction pathways that are independent of cyclic AMP. P2 purinoceptor agonists, ATP and UTP, have recently been shown to enhance Cl-secretion in CF nasal epithelial cells (Mason et al., 1991; Stutts et al., 1992) , and have been tested in clinical trials (Knowles et al., 1991) . Other purine analogues, namely P1 purinoceptor agonists like adenosine (ADO), have also been shown to stimulate Cl-transport in secretory epithelia (Pratt et al., 1986; Barrett et al., 1990) including airway cells. We questioned whether P1 ' Author for correspondence.
purinoceptor-mediated Cl secretion is preserved in CF airway epithelial cells, and, if so, what signalling mechanism is involved. We investigated the effects of various PI purinoceptor agonists in a simian virus 40 (SV40)-transformed CF phenotype airway epithelial cell line, CFPEo- .
Purinoceptors have been classified after Burnstock (1990) as P1 and P2 subtypes, based on their preferences for ADO or adenine nucleotides. A P1 receptor typically responds to these agents in the rank order of potency of ADO > AMP > ADP > ATP and is therefore also named adenosine receptor; the responsiveness of the P2 subtype usually shows the reverse order (Stiles, 1991; Olah & Stiles, 1992) . P1 receptors are further subclassified into A1 and A2 adenosine receptor subtypes. A1 adenosine receptor (A1AR) generally responds to ADO analogues in the potency order of R-phenylisopropyl adenosine (R-PIA)> 2-chloro-adenosine (2-Cl-ADO) > 5'-Nethylcarboxamine adenosine (NECA) (Ukena et al., 1987; Williams, 1987) ; whereas A2AR responds in the order of NECA>2-Cl-ADO>R-PIA (Stiles, 1991) . A1AR has been shown to couple to a variety of effector systems, including adenylate cyclase, guanylate cyclase, membrane ion channels, and phospholipases (Olsson & Pearson, 1990) . So far, the only established effector system for A2AR is adenylate cyclase (Stiles, 1991) . In this study, we demonstrate that P1 purinoceptor agonists act on A2AR to activate airway Clsecretion via a Ca2'-dependent signalling pathway, which appears to be preserved in CF airway epithelial cells.
Methods

Cell culture
CFPEo-cells were transformed as described [Ca2J]i was determined as described by Grynkiewicz et al. (1985) .
Electrophysiology
Whole-cell patch-clamp experiments were performed in single CFPEo-cells grown on glass coverslips 1-2 days following seeding. Cells/coverslip were placed in a 1 ml acrylic chamber on the stage of a Zeiss IM inverted microscope and bathed in a solution containing (in mM) Tris-Cl 170, MgCl2 1, CaCl2 2.5, glucose 15, and HEPES 10 (pH 7.4; -330 mosm kg-'), at 25-30°C. The pipette solution contained (in mM): CsCl 140, MgCl2 2, EGTA 1, MgATP 2, glucose 10 and HEPES 5 (pH 7.35; -300 mosm kg-'). The bath solution was made -30 mosm kg-' hypertonic compared with the pipette solution to prevent hyponicity-induced Cl-current (Worrell et al., 1989) . Micropipettes were made as described by Hamill et al. (1981) and had a tip resistance of 2-3 MQ. Whole-cell currents were recorded with an Axopatch amplifier (Axon Instruments, Foster City, CA, U.S.A.). Voltageclamp protocols were run with an aid of a Tecmar 12-bit A/D-D/A converter and an IBM-AT computer. Signals, filtered at 1 kHz, were displayed on a strip-chart recorder and stored in floppy disks. Data were analyzed by means of pClamp, version 5.5 (Axon Instruments).
Materials
CPCA, DMPX and N6-phenyladenosine were purchased from Research Biochemical Inc. (Nalick, MA, U.S.A.). Fura-2-acetoxymethyl ester (fura-2-AM), 1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid, tetracesium salt (BAPTA) and pluoronic F127 were from Molecular Probes (Eugene, OR, U.S.A.). Other reagents were from Sigma Chemical Co. (St. Louis, MO, U.S.A.). Synthetic peptides CaMK and CaMK [284] [285] [286] [287] [288] [289] [290] [291] [292] [293] [294] [295] [296] [297] [298] [299] [300] [301] [302] were kindly provided by Dr Howard Schulman, Stanford University.
Results
Effect ofpurinoceptor agonists on 125I efflux rate
We initially studied and compared the effect of adenine nucleotides ATP, ADP, and 5'-AMP on "25I efflux rate in CFPEo-cells to test whether the P2 purinoceptor plays a predominant role in regulating membrane conductive Cltransport. We concentrated on CF phenotype airway cells since P2 purinoceptor agonists are in clinical trial as a therapeutic agent to improve airway function in CF, presumably by enhancing Cl-secretion. 1251 was used in the efflux assay because iodine is selectively transported through the Cl-conductive pathway by epithelial cells (Widdicombe & Welsh, 1980) . As illustrated in Figure purinocepter.
To decipher the subtype of P1 purinoceptors involved in purine analogue-induced Cl-secretion, the effects of P1 selective purinocepter agonists were subsequently examined and compared at 10 and 100 ,UM, respectively. As shown in Figure   Ic and Figure 2 , among the P1 agonists tested, 125I efflux rate was stimulated in the order of NECA>2-Cl-ADO> R-PIA.
CPCA is a potent A2AR agonist (Bruns et al., 1986; Daly, 1982) . We have tested the effect of CPCA (2 JAM) compared with that of a selective AAR agonist, N6-phenyl ADO (10 pM; Daly et al., 1986) . As shown in Figure Id (Figure 3a at a lower dose (not shown). In concert with the 1251 efflux data (see Figure Id) Figure 4a ) and on 1251I efflux (Figure 4b ). These results suggest that P1 purinoceptor agonists act mainly on A2AR to stimulate Cl-secretion, which is mediated through a Ca2'-dependent pathway.
Activation of membrane Cl-channels by P, purinoceptor agonists: role of CaMK Bath application of ADO (1 mM) induced an outwardlyrectifying whole-cell current characteristic of Ca2+-stimulated membrane Cl-current (Figure 5a ). The recorded current should be predominantly due to flow of Cl-ions because Na+ and K+ were omitted in the bath and pipette solutions and Cs', used to replace pipette K+, is known to block K+ channels. The reversal potential was near 0 mV (Figure 5b ), in good agreement with the predicted Nernst potential for Cl-(-5mV). Ca2+/calmodulin-dependent protein kinase (CaMK) has been shown to mediate Ca2+-stimulated Cl-currents in secretory epithelia (Worrell & Frizzell, 1991; Chan et al., 1992; Wagner et al., 1992) and human T lymphocytes (Nishimoto et al., 1991) . The Ca2"-dependent pathway involves CaMK-mediated phosphorylation of a Cl channel/ transport protein entirely separate from CFTR, since antisense depletion of CFTR protein eliminates cyclic AMPdependent but not Ca2"-dependent C1-secretion The resting membrane potential was held at -70 mV. To examine the current-voltage (I-V) relation of a recorded current, membrane potential was sequentially altered from -100 to + 100 mV in 50 mV steps, using the voltage-clamp protocol given in the inset. Data were averaged over the final 50 ms of the current pulses. (b) I-V relations of Cl-currents recorded at baseline (@) and after stimulation (0) of ADO. Data were normalized by dividing by cell capacitance, an index of cell surface area , and presented as mean ± s.e.mean (n = 7 cells).
Discussion
ADO and adenine nucleotide induced Cl-(I-) conductive loss in the CF airway epithelial cell lines, CFPEo-and CFNPEo-. In both cases, ADO was the most potent stimulant among the four purine analogues tested. Thus, under our experimental conditions, the P1 purinoceptor agonist, ADO was more effective in stimulating Cl-secretion than the P2 agonist, ATP. (Pratt et al., 1986 of -60% that of normal cells (Frizzell et at., 1986; Boucher et at., 1989 Worrell & Frizzell, 1991 (Stiles, 1991) .
How do these findings compare to previously published reports? The exact nature of the purinoceptor that is linked to ion transport in secretory epithelia is unclear from the cumulative published literature. Several previous published studies, most notably of canine tracheal epithelium (Pratt et al., 1986) and human T84 colonic carcinoma cells (Barrett et al., 1990) , demonstrated ADO-induced (Knowles et al., 1991) and in freshly excised intact tissue (Mason et al., 1991) , by means of a P2 receptor.
The potency order of nucleotide analogues and responsiveness to UTP suggested the presence of one or more P2 receptor subtypes distinct from the previously characterized P2,X and P2y subtypes (Burnstock & Kennedy, 1985) . ADO was relatively ineffective in mediating ion transport. In this case, nucleotide-induced ion transport changes were linked to changes in [Ca2+]i and were preserved in CF airway epithelium. However, changes in short-circuit current were attributed to increments in the rate of Na+ absorption (Barrett et al., 1990) rather than primarily through changes in Cl-secretion. Primary changes in Na+ absorption could not explain, however, our whole-cell patch-clamp studies of CaMK-mediated outwardly rectifying Clcurrents. Differences in the findings with respect to the purinoceptor subtype and ionic mechanism may be partially attributable to studies of relatively intact human epithelium (Barrett et al., 1990) vs. studies of the transformed airway epithelial cells. In the relatively more intact tissue preparation, metabolism of ADO may mask ADO-induced changes in Cl-secretion. In support of this, it has been shown that ADO is relatively impotent in causing Cl-secretion in rabbit ileal mucosa because of uptake and metabolism (Dobbinset at., 1984 (Cushley et al., 1984) . This side-effect of ADO can be attenuated by nedocromil sodium and sodium cromoglycate (Crimi et al., 1986) .
In conclusion, our results suggest that P1 purinoceptor agonists act via A2AR to stimulate Cl-secretion in airway epithelial cells. The stimulatory effeqt of P1 agonists is mediated via a Ca2"-dependent signalling pathway, which appears to be, at least partially, preserved in CF cells.
